Squarepoint Ops LLC Selecta Biosciences Inc Transaction History

Squarepoint Ops LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.62 - $0.85 $40,689 - $55,784	-65,629 Reduced 37.65%	108,678 $91,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.35 $97,317 - $196,087	145,250 Added 499.88%	174,307 $120,000
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.4 $85,152 - $114,627	-81,877 Reduced 73.81%	29,057 $32,000
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $127,574 - $209,665	110,934 New	110,934 $154,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $18,599 - $38,864	27,760 New	27,760 $36,000
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $18,641 - $50,166	-15,156 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $43,800 - $67,141	15,156 New	15,156 $49,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.62 $39,369 - $54,132	-11,717 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $33,041 - $58,702	11,717 New	11,717 $49,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $117,486 - $203,991	-40,235 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $11,539 - $24,063	7,036 Added 21.19%	40,235 $122,000
Q3 2020 Nov 16, 2020	BUY	$2.18 - $2.84 $72,373 - $94,285	33,199 New	33,199 $82,000
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $181,012 - $401,590	-98,914 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $148,371 - $447,091	98,914 New	98,914 $238,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.